about
Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression.Exploring molecular insights into the interaction mechanism of cholesterol derivatives with the Mce4A: A combined spectroscopic and molecular dynamic simulation studies.Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationshipsIdentification and Evaluation of Inhibitors of Lipase from using Virtual High-Throughput Screening and Molecular Dynamics StudiesStructural and functional impact of non-synonymous SNPs in the CST complex subunit TEN1: structural genomics approachStructural Analysis and Conformational Dynamics of STN1 Gene Mutations Involved in Coat Plus Syndrome.Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation StudiesUnraveling Binding Mechanism of Alzheimer's Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative DiseasesImpact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanomaMutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal CarcinogenesisInvestigation of deleterious effects of nsSNPs in the POT1 gene: a structural genomics-based approach to understand the mechanism of cancer developmentVirtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1)Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapyIdentification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer TherapyInvestigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanomaIdentification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapyTargeting metacaspase-3 from Plasmodium falciparum towards antimalarial therapy: A combined approach of in-silico and in-vitro investigationIdentification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancerInvestigating the structural features of chromodomain proteins in the human genome and predictive impacts of their mutations in cancersInvestigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapyIdentification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brainDiscovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer TherapyMARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease TherapyInsights into the Conserved Regulatory Mechanisms of Human and Yeast AgingDesign and Development of Novel Urea, Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine Kinase 1
P50
Q47402384-BA0C5CB8-9A50-415F-BEF0-C154DE1F3B98Q50060976-7EB50627-7F8E-46C2-B4A7-52DF5E17A6E6Q52312868-A9D184FA-B266-45D1-97AB-4459538243F2Q58554766-7A8FDDFE-104E-472A-843E-A6DA8E87A946Q64258727-5DB8800F-1E6C-48B4-B680-641CD69C2BE0Q64262785-BBD85A7B-B6AD-4BCC-A2E9-754893FC4289Q64977771-7AA107CC-A68C-4FBF-A5B8-5CFC5228DCECQ89762219-12EF58F3-9063-4DDE-9139-54B7C4454825Q90163950-D984C32C-CACB-4C3D-879F-82AD579F1965Q90243222-1B63AAA8-8612-4C9C-986E-6738E66AD837Q90484294-995985C3-A81D-4F9F-82C7-FECE39324198Q90576090-2315C912-9717-416F-ADD8-815C848E57CEQ90788681-E45E1651-C52C-4DA1-8E86-DCAEFC69BB70Q91854913-E9BB43AF-1F61-4309-9FF8-8CE2EE095C15Q92051863-25199E7F-AEA1-4E97-99F6-9E685663E9C1Q92054460-5F35AE57-9368-45AF-9F5B-6C6870CA2EE0Q92166881-72C7AB2B-335D-469A-93F4-6439B5FD1F81Q92225269-115F784A-D295-4ACB-AEE2-E0F2C029F33FQ92404108-C180954C-46EA-43EF-BFE5-0650E955CEB9Q92429900-97E98414-764D-4AC5-A964-181C67DD7853Q92656759-5A6B72DE-B94F-40D1-BB4E-D7AC315D6AEBQ92985960-84375ECF-03CE-45D6-A6E1-6F1FAB97F4BAQ93183709-4F5D5E2A-673C-4566-BAA6-39674250ED8EQ95303827-CF897957-4546-42B6-BC35-CA97E36606FEQ95656057-81407831-DFCA-4786-935E-EA83D40FF275Q96294212-CB4F6EF2-3CCD-4C23-9825-3926DED478D4Q96294413-E06FB54B-90C9-49EC-AB7E-C7B5D7C7C484
P50
description
researcher
@en
wetenschapper
@nl
name
Taj Mohammad
@en
Taj Mohammad
@nl
type
label
Taj Mohammad
@en
Taj Mohammad
@nl
prefLabel
Taj Mohammad
@en
Taj Mohammad
@nl
P31
P496
0000-0002-0399-4835